Weilai H. Tong

Department Of Otolaryngology Head And Neck Surgery
Nanchang, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

HAO2 inhibits the growth and lipid metabolism of head and neck squamous cell carcinoma by enhancing MYH9 ubiquitination mediated by STUB1 and USP14.

HAO2 inhibits the growth and lipid metabolism of head and neck squamous cell carcinoma by enhancing MYH9 ubiquitination mediated by STUB1 and USP14.

Journal: Biochimica et biophysica acta. Molecular basis of disease

Published: November 25, 2025

High expression of AURKB promotes malignant phenotype of osteosarcoma cells by activating nuclear factor-κB signaling via DHX9

High expression of AURKB promotes malignant phenotype of osteosarcoma cells by activating nuclear factor-κB signaling via DHX9

Journal: Nan fang yi ke da xue xue bao = Journal of Southern Medical University

Published: December 26, 2024

Targeting the SYVN1-EGFR axis: a breakthrough strategy for TKI-resistant NSCLC.

Targeting the SYVN1-EGFR axis: a breakthrough strategy for TKI-resistant NSCLC.

Journal: Cell death & disease

Published: November 25, 2024

SPICE1 promotes osteosarcoma growth by enhancing the deubiquitination of FASN mediated by USP10.

SPICE1 promotes osteosarcoma growth by enhancing the deubiquitination of FASN mediated by USP10.

Journal: Journal of translational medicine

Published: November 12, 2024

VCP enhances autophagy-related osteosarcoma progression by recruiting USP2 to inhibit ubiquitination and degradation of FASN.

VCP enhances autophagy-related osteosarcoma progression by recruiting USP2 to inhibit ubiquitination and degradation of FASN.

Journal: Cell death & disease

Published: April 21, 2024

KRT80 Promotes Lung Adenocarcinoma Progression and Serves as a Substrate for VCP.

KRT80 Promotes Lung Adenocarcinoma Progression and Serves as a Substrate for VCP.

Journal: Journal of Cancer

Published: October 31, 2023

USP3 promotes osteosarcoma progression via deubiquitinating EPHA2 and activating the PI3K/AKT signaling pathway.

USP3 promotes osteosarcoma progression via deubiquitinating EPHA2 and activating the PI3K/AKT signaling pathway.

Journal: Cell death & disease

Published: October 02, 2023

AURKB targets DHX9 to promote hepatocellular carcinoma progression via PI3K/AKT/mTOR pathway.

AURKB targets DHX9 to promote hepatocellular carcinoma progression via PI3K/AKT/mTOR pathway.

Journal: Molecular carcinogenesis

Published: September 03, 2023

YY1 is regulated by ALKBH5-mediated m6A modification and promotes autophagy and cancer progression through targeting ATG4B.

YY1 is regulated by ALKBH5-mediated m6A modification and promotes autophagy and cancer progression through targeting ATG4B.

Journal: Aging

Published: May 30, 2023

CircREOS suppresses lipid synthesis and osteosarcoma progression through inhibiting HuR-mediated MYC activation.

CircREOS suppresses lipid synthesis and osteosarcoma progression through inhibiting HuR-mediated MYC activation.

Journal: Journal of Cancer

Published: February 01, 2023

Alpinetin inhibits neuroinflammation and neuronal apoptosis via targeting the JAK2/STAT3 signaling pathway in spinal cord injury.

Alpinetin inhibits neuroinflammation and neuronal apoptosis via targeting the JAK2/STAT3 signaling pathway in spinal cord injury.

Journal: CNS neuroscience & therapeutics

Published: November 04, 2022

Aucubin promoted neuron functional recovery by suppressing inflammation and neuronal apoptosis in a spinal cord injury model.

Aucubin promoted neuron functional recovery by suppressing inflammation and neuronal apoptosis in a spinal cord injury model.

Journal: International immunopharmacology

Published: May 23, 2022

Showing 1-12 of 15

Last Updated: 09/26/2026